Candel Therapeutics CADL
NASDAQ CADL
$9.22 -0.13 (-1.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Candel Therapeutics (CADL) Price to Sales (2021 - 2023)

Updated

Candel Therapeutics' Price to Sales came in at 200.21 for Q1 2023, down 83.0% from 1177.81 a year earlier and down 52.0% from the prior quarter.

Analysis

Candel Therapeutics (CADL) Price to Sales (2021 - 2023) Analysis & Trends

For FY2022, Candel Therapeutics' Price to Sales was 414.13, down 64.9% from FY2021.

  • Going back by year, Price to Sales was 1180.70 in FY2021.
  • Year-over-year, Price to Sales has declined for three consecutive quarters.
  • Business Quant data shows CADL's Price to Sales at 417.47 (Q4 2022), 731.62 (Q3 2022) and 754.92 (Q2 2022) in the three quarters before Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Candel Therapeutics 711.71 Mn 108.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 200.21
Dec 31, 2022 417.47
Sep 30, 2022 731.62
Jun 30, 2022 754.92
Mar 31, 2022 1,177.81
Dec 31, 2021 1,190.22
Sep 30, 2021 2,039.12
API Access

Candel Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CADL&period=max&api_key=YOUR_API_KEY